ID   Karpas-417
AC   CVCL_2542
SY   Karpas 417; KARPAS 417
DR   ECACC; 06100302
DR   Wikidata; Q54899499
DR   Ximbio; 152421
RX   CelloPub=CLPUB00604;
RX   PubMed=15621787;
WW   https://www.keatslab.org/myeloma-cell-lines/hmcl-characteristics
CC   Doubling time: ~60 hours (ECACC; Ximbio).
CC   Derived from sampling site: Peripheral blood.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 20-05-21; Version: 12
//
RX   CelloPub=CLPUB00604;
RA   Chow S.;
RT   "Targeted capture and sequencing of immunoglobulin rearrangements
RT   in multiple myeloma to enable detection of minimal residual disease.";
RL   Thesis MSc (2017), University of Toronto, Canada.
//
RX   PubMed=15621787; DOI=10.1080/10428190400002244;
RA   Karpas A., Harder L., Czepulkowski B.H., Bloxham D., Saward R.,
RA   Dremucheva A., Siebert R.;
RT   "Studies of four new human myeloma cell lines.";
RL   Leuk. Lymphoma 46:101-112(2005).
//